Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.
Stock data | 2024 | Change |
---|---|---|
Price | $0.0007 | N/A |
Market Cap | $26.24K | N/A |
Shares Outstanding | 37.49M | N/A |
Employees | 2.00 | N/A |